Home/Filings/4/0001104659-22-118549
4//SEC Filing

CLACKSON TIMOTHY P 4

Accession 0001104659-22-118549

CIK 0001745020other

Filed

Nov 13, 7:00 PM ET

Accepted

Nov 14, 4:12 PM ET

Size

5.0 KB

Accession

0001104659-22-118549

Insider Transaction Report

Form 4
Period: 2022-11-11
CLACKSON TIMOTHY P
DirectorPresident and CEO
Transactions
  • Purchase

    Common Stock

    2022-11-11$6.80/sh+2,500$16,995351,030 total
Footnotes (1)
  • [F1]The price reported is a weighted average price of shares purchased. These shares were purchased in multiple transaction at prices ranging from $6.595 to $6.807, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price.

Issuer

Theseus Pharmaceuticals, Inc.

CIK 0001745020

Entity typeother

Related Parties

1
  • filerCIK 0001242992

Filing Metadata

Form type
4
Filed
Nov 13, 7:00 PM ET
Accepted
Nov 14, 4:12 PM ET
Size
5.0 KB